Free Trial

Astera Labs, Inc. $ALAB Stock Position Increased by NFSG Corp

Astera Labs logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • NFSG Corp increased its Astera Labs stake by 83% in the third quarter, bringing its holdings to 10,623 shares valued at approximately $3.78 million. Institutional investors collectively own 60.47% of ALAB.
  • Astera Labs insiders sold 408,558 shares worth about $127.3 million over the past three months, including sales by General Counsel Philip Mazzara and Director Stefan Dyckerhoff under tax-withholding and pre-arranged trading arrangements.
  • Analysts maintain a “Moderate Buy” consensus with an average $348.33 price target, while the company recently exceeded quarterly earnings and revenue expectations, reporting $0.80 EPS and $392.4 million in revenue.
  • Five stocks to consider instead of Astera Labs.

NFSG Corp lifted its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 83.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,623 shares of the company's stock after buying an additional 4,818 shares during the quarter. NFSG Corp's holdings in Astera Labs were worth $3,781,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in ALAB. Assenagon Asset Management S.A. lifted its position in shares of Astera Labs by 886.9% during the 3rd quarter. Assenagon Asset Management S.A. now owns 74,746 shares of the company's stock valued at $26,607,000 after buying an additional 67,172 shares in the last quarter. State of Alaska Department of Revenue increased its holdings in Astera Labs by 6.4% in the 3rd quarter. State of Alaska Department of Revenue now owns 2,507 shares of the company's stock worth $892,000 after acquiring an additional 150 shares in the last quarter. Gunderson Capital Management LLC purchased a new stake in Astera Labs in the 3rd quarter worth $250,000. Formuepleje A S purchased a new stake in Astera Labs in the 3rd quarter worth $500,000. Finally, B.A. Schrock Wealth Management Inc. acquired a new position in Astera Labs during the third quarter worth $300,000. Hedge funds and other institutional investors own 60.47% of the company's stock.

Insider Buying and Selling at Astera Labs

In other news, General Counsel Philip Mazzara sold 6,801 shares of the company's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the sale, the general counsel owned 96,542 shares of the company's stock, valued at $32,872,551. This represents a 6.58% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan Dyckerhoff sold 8,994 shares of the stock in a transaction dated Wednesday, October 7th. The shares were sold at an average price of $376.06, for a total transaction of $3,382,283.64. Following the completion of the sale, the director owned 2,648 shares of the company's stock, valued at $995,806.88. This trade represents a 77.25% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 408,558 shares of company stock valued at $127,306,034. 10.40% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

ALAB has been the subject of a number of research analyst reports. Roth Capital restated a "buy" rating and set a $450.00 price objective on shares of Astera Labs in a research report on Wednesday, August 5th. Susquehanna lifted their target price on shares of Astera Labs from $230.00 to $275.00 and gave the company a "neutral" rating in a research report on Friday, July 31st. Zacks Research lowered shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research report on Monday, October 5th. Jefferies Financial Group boosted their target price on shares of Astera Labs from $270.00 to $450.00 and gave the stock a "buy" rating in a research note on Wednesday, August 5th. Finally, Needham & Company LLC boosted their target price on shares of Astera Labs from $260.00 to $425.00 and gave the stock a "buy" rating in a research note on Wednesday, August 5th. Eleven equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $348.33.

Read Our Latest Analysis on ALAB

Astera Labs Stock Performance

Shares of ALAB opened at $301.98 on Friday. Astera Labs, Inc. has a one year low of $97.89 and a one year high of $499.48. The stock has a market capitalization of $52.39 billion, a price-to-earnings ratio of 193.73 and a beta of 3.68. The stock has a 50 day moving average price of $315.82 and a 200 day moving average price of $297.08.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%. The firm's revenue was up 104.5% compared to the same quarter last year. During the same period in the prior year, the company earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, analysts predict that Astera Labs, Inc. will post 2.70 earnings per share for the current year.

About Astera Labs

(Free Report)

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.

Recommended Stories

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Astera Labs Right Now?

Before you consider Astera Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astera Labs wasn't on the list.

While Astera Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines